CDX ETF

KITCHENER, ON / ACCESSWIRE / December 16, 2024 / Cloud DX Inc. ("Cloud DX") (TSXV:CDX)(OTCQB:CDXFF) has announced the sale of its fully owned subsidiary, Cloud Diagnostics Canada ULC (the "Company"), to 1493907 B.C. Ltd (the "Purchaser").

CDX has changed from a high yield ETF with a built-in hedge to a multi-asset fund. This new setup brings more risk, which means it is not a good choice for high yield portfolios. Additionally, current high yield credit spreads are at their lowest in ten years, making the overall market conditions poor for high yield investments.

HAMPTON, N.J., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) has announced that they have given the first dose of CDX-622 to a patient in their Phase 1a study involving healthy volunteers. CDX-622 is a bispecific antibody designed to target two key pathways that contribute to chronic inflammation, effectively neutralizing the alarmin thymic stromal lymphopoietin (TSLP) and reducing mast cells by depriving them of stem cell factor (SCF).

The Simplify High Yield PLUS Credit Hedge ETF uses a mix of high-quality and low-quality stocks to protect against credit risk, providing a positive carry credit hedge. Although CDX helps with credit risk, it doesn't protect against rising interest rates, which can be a problem when rates go up. I recommend buying CDX because it can make high-yield bonds more attractive by reducing the risks during a downturn in credit.

Hemogenyx Pharmaceuticals PLC (LSE:HEMO, OTC:HOPHF) has revealed that it is working on a new version of its bi-specific CDX antibody to treat relapsed or refractory acute myeloid leukaemia (AML), and it may also be useful for preparing patients for bone marrow transplants. This upgraded CDX, created with Lonza's bYlok bispecific pairing technology, has shown much better effectiveness in lab tests, and additional animal studies are underway.

High yield bonds often experience more fluctuations in credit risk, and during tough market times, credit spreads can increase rapidly, leading to a quick loss of income. CDX uses credit hedging methods to reduce this credit risk. It can implement credit hedges that are closely linked to credit markets, such as CDS, CDX, and CDX options.

CDX outperformed competitors HYG and JNK in the past year from a total return perspective, and with a better drawdown profile. CDX utilizes put spreads on the S&P 500 to hedge downside moves, providing insurance against market losses. The fund offers a lower drawdown in a market sell-off due to its embedded hedge profile and put spreads, making it a smart choice for investors.

KITCHENER, ON / ACCESSWIRE / June 6, 2024 / Cloud DX Inc. ("Cloud DX") (TSXV:CDX)(OTCQB:CDXFF) today reports that its wholly-owned subsidiary, Cloud Diagnostics Canada ULC (the "Company"), with the authorization and approval of its board of directors (the "Board"), has filed a Notice of Intention to Make a Proposal ("NOI") pursuant to the provisions of the Bankruptcy and Insolvency Act (Canada). Cloud Diagnostics Canada ULC is a material subsidiary of Cloud DX Inc, accounting for most of the Company's revenues.